Keywords: astrazeneca, hit, news, approval, delay, lipid-lowerer, crestor

AstraZeneca hit by news of US approval delay for lipid-lowerer Crestor

Article | 06 May 2002

Print This

AstraZeneca shares fell more than 5% to L33.40 on the day of itsfirst-quarter results meeting (see also page 3) as news of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in